Pharvaris B.V. operates as a clinical-stage company. The Company focuses on the discovery and development of novel oral B2-receptor antagonists for the treatment of patients. Pharvaris serves customers in the Netherlands and Switzerland.
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.
This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.
Explore
Get Premium